Pangaea Oncology Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	16.73	16.79	9.95	6.68	6.71
Revenue Growth (YoY)	-0.32%	68.64%	49.12%	-0.48%	8.61%
Cost of Revenue	2.58	2.74	2.4	2.73	1.65
Gross Profit	14.15	14.05	7.56	3.94	5.05
Selling, General & Admin	15.25	14.04	9.35	5.35	4.41
Other Operating Expenses	0.01	-0.36	-0.16	0.04	0.29
Operating Expenses	18.04	16.24	11	6.64	5.7
Operating Income	-3.89	-2.19	-3.44	-2.7	-0.64
Interest Expense	-0.3	-0.3	-0.13	-0.19	-0.25
Interest & Investment Income	0	0.02	0.12	0.02	0
Earnings From Equity Investments	-	-	-0.06	-0.16	-0.19
Currency Exchange Gain (Loss)	0.01	-0.01	-0.01	0	-0.01
Other Non Operating Income (Expenses)	0.15	0.43	0.13	0.14	0.09
EBT Excluding Unusual Items	-4.02	-2.06	-3.39	-2.88	-1.01
Impairment of Goodwill	-	-	-0.51	-	-
Gain (Loss) on Sale of Investments	-	-	0.39	0.04	-0.09
Asset Writedown	-	0.36	-	-	-
Pretax Income	-4.02	-1.69	-3.51	-2.84	-1.1
Income Tax Expense	-0.46	-0.5	1.29	-0.11	-0.46
Earnings From Continuing Operations	-3.57	-1.2	-4.79	-2.72	-0.64
Earnings From Discontinued Operations	-	-0.07	-	-	-
Net Income to Company	-3.57	-1.27	-4.79	-2.72	-0.64
Minority Interest in Earnings	-0.03	0.1	0.14	0.01	-
Net Income	-3.6	-1.17	-4.66	-2.71	-0.64
Net Income to Common	-3.6	-1.17	-4.66	-2.71	-0.64
Shares Outstanding (Basic)	36	-	30	30	23
Shares Outstanding (Diluted)	36	-	30	30	23
Shares Change (YoY)	-	-	-0.98%	35.11%	20.34%
EPS (Basic)	-0.10	-	-0.15	-0.09	-0.03
EPS (Diluted)	-0.10	-	-0.15	-0.09	-0.03
Free Cash Flow	-2.97	-5.05	-2.65	-3.7	-2.53
Free Cash Flow Per Share	-0.08	-	-0.09	-0.12	-0.11
Gross Margin	84.56%	83.69%	75.92%	59.06%	75.36%
Operating Margin	-23.25%	-13.03%	-34.59%	-40.40%	-9.56%
Profit Margin	-21.49%	-6.95%	-46.77%	-40.63%	-9.57%
Free Cash Flow Margin	-17.74%	-30.08%	-26.66%	-55.36%	-37.67%
EBITDA	-2.6	-0.85	-2.69	-2.31	-0.27
EBITDA Margin	-15.55%	-5.03%	-27.07%	-34.62%	-4.02%
D&A For EBITDA	1.29	1.34	0.75	0.39	0.37
EBIT	-3.89	-2.19	-3.44	-2.7	-0.64
EBIT Margin	-23.25%	-13.03%	-34.59%	-40.40%	-9.56%
Revenue as Reported	-	-	8	4.37	-
Advertising Expenses	0.11	0.1	0.18	0.07	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.